In this case, the recruited cells may serve as a physical barrier to prevent later immune cells from approaching and attacking the tumor cells Also, the recruited immune cells can also secrete cytokines (such as IL1-β, TGF-β) that continue to assimilate later recruited immune cells as ‘tumor-friendly’ phenotypes (16, 17). The gene discussed is IL1B; the disease is neoplasm.